Global Oncology Academy - Global Oncology Academy

Global Oncology Academy

Global Oncology Academy

Enhance your practice with CME
and tools that focus on the management
and treatment of patients with cancer.

Popular

Cracking the Code in Localized, nmCSPC: Risk, Treatment, and Timing
Cracking the Code in Localized, nmCSPC: Risk, Treatment, and Timing
CME/CE
Cracking the Code in Localized, nmCSPC: Risk, Treatment, and Timing
Neeraj Agarwal, MD, FASCO; Rana McKay, MD
0.25 credits
- Neeraj Agarwal, MD, FASCO
- Rana McKay, MD
0.25 credits
How Genetic Testing Guides Personalized mBC Care
How Genetic Testing Guides Personalized mBC Care
On the Frontlines of Metastatic Breast Cancer
How Genetic Testing Guides Personalized mBC Care
Alexandria May, PharmD, BCPS; Marie Wood, MD
- Alexandria May, PharmD, BCPS
- Marie Wood, MD
MCED Testing for Breast Cancer: Opportunities and Limitations
MCED Testing for Breast Cancer: Opportunities and Limitations
On the Frontlines of Metastatic Breast Cancer
MCED Testing for Breast Cancer: Opportunities and Limitations
Alexandria May, PharmD, BCPS; Marie Wood, MD
- Alexandria May, PharmD, BCPS
- Marie Wood, MD
Building on Progress in ALK+ Non-Small Cell Lung Cancer Treatment
Building on Progress in ALK+ Non-Small Cell Lung Cancer Treatment
Project Oncology®
Building on Progress in ALK+ Non-Small Cell Lung Cancer Treatment
Urs Weber, MD
- Urs Weber, MD
Side Effect Management in ALK+ Non-Small Cell Lung Cancer Care
Side Effect Management in ALK+ Non-Small Cell Lung Cancer Care
Project Oncology®
Side Effect Management in ALK+ Non-Small Cell Lung Cancer Care
Urs Weber, MD
- Urs Weber, MD
Rising Colorectal Cancer in Young Adults: Implications for Screening
Rising Colorectal Cancer in Young Adults: Implications for Screening
Clinician's Roundtable
Rising Colorectal Cancer in Young Adults: Implications for Screening
Christopher Cann, MD
- Christopher Cann, MD
Post-BCMA Treatment Selection in R/R Multiple Myeloma
Post-BCMA Treatment Selection in R/R Multiple Myeloma
Project Oncology®
Post-BCMA Treatment Selection in R/R Multiple Myeloma
Steve Jackson, PharmD; Nisha Joseph, MD
- Steve Jackson, PharmD
- Nisha Joseph, MD
ADT Intensification: The Evidence You Can’t Afford to Miss
ADT Intensification: The Evidence You Can’t Afford to Miss
MinuteCE®
ADT Intensification: The Evidence You Can’t Afford to Miss
Scott T. Tagawa, MD, MS; Mary-Ellen Taplin, MD
1.00 program credit
- Scott T. Tagawa, MD, MS
- Mary-Ellen Taplin, MD
1.00 program credit

Medical News

Medical News
Oncologist Preferences in First-Line Alk-Positive Metastatic NSCLC
06/30/2026
Read more
Medical News
Mediterranean Diet, Fat Intake, and Lung Cancer Outcomes
06/30/2026
Read more
Medical News
Longitudinal Mammographic Deep Learning Risk Scores Track Future Cancer
06/29/2026
Read more
Medical News
Artificial Intelligence in Histopathology and Cytopathology
06/29/2026
Read more

CME/CE

Molecular Profiling in mHSPC: Informing Treatment Selection
Molecular Profiling in mHSPC: Informing Treatment Selection
MinuteCE®
Molecular Profiling in mHSPC: Informing Treatment Selection
Scott T. Tagawa, MD, MS; Mary-Ellen Taplin, MD
1.00 program credit
- Scott T. Tagawa, MD, MS
- Mary-Ellen Taplin, MD
1.00 program credit
Case: Implementing ADT Intensification in mHSPC
Case: Implementing ADT Intensification in mHSPC
MinuteCE®
Case: Implementing ADT Intensification in mHSPC
Scott T. Tagawa, MD, MS; Mary-Ellen Taplin, MD
1.00 program credit
- Scott T. Tagawa, MD, MS
- Mary-Ellen Taplin, MD
1.00 program credit
Winning the Battle Against Side Effects: Adverse Event Management in HSPC
Winning the Battle Against Side Effects: Adverse Event Management in HSPC
MinuteCE®
Winning the Battle Against Side Effects: Adverse Event Management in HSPC
Scott T. Tagawa, MD, MS; Mary-Ellen Taplin, MD
1.00 program credit
- Scott T. Tagawa, MD, MS
- Mary-Ellen Taplin, MD
1.00 program credit
SERENA-6: Acting on ESR1 Mutations in Advanced Breast Cancer
SERENA-6: Acting on ESR1 Mutations in Advanced Breast Cancer
MinuteCE®
SERENA-6: Acting on ESR1 Mutations in Advanced Breast Cancer
Erica L. Mayer, MD, MPH
0.50 program credits
- Erica L. Mayer, MD, MPH
0.50 program credits

Clinical Practice

Rethinking Frontline Care in HER2- Metastatic Breast Cancer
Rethinking Frontline Care in HER2- Metastatic Breast Cancer
On the Frontlines of Metastatic Breast Cancer
Rethinking Frontline Care in HER2- Metastatic Breast Cancer
Alexandria May, PharmD, BCPS; Tiffany Traina, MD, FASCO
- Alexandria May, PharmD, BCPS
- Tiffany Traina, MD, FASCO
Evolving Treatment Strategies in ALK+ Non-Small Cell Lung Cancer
Evolving Treatment Strategies in ALK+ Non-Small Cell Lung Cancer
Project Oncology®
Evolving Treatment Strategies in ALK+ Non-Small Cell Lung Cancer
Jorge Nieva, MD
- Jorge Nieva, MD
Patient-Centered Care in ALK+ Non-Small Cell Lung Cancer
Patient-Centered Care in ALK+ Non-Small Cell Lung Cancer
Project Oncology®
Patient-Centered Care in ALK+ Non-Small Cell Lung Cancer
Jorge Nieva, MD
- Jorge Nieva, MD
Beyond ALK Inhibition: Addressing Unmet Needs in Non-Small Cell Lung Cancer
Beyond ALK Inhibition: Addressing Unmet Needs in Non-Small Cell Lung Cancer
Project Oncology®
Beyond ALK Inhibition: Addressing Unmet Needs in Non-Small Cell Lung Cancer
Urs Weber, MD
- Urs Weber, MD

Programs

The Evolving TROP2-directed ADC Landscape in Metastatic NSCLC
The Evolving TROP2-directed ADC Landscape in Metastatic NSCLC
Oncology and Hematology
The Evolving TROP2-directed ADC Landscape in Metastatic NSCLC
Nicolas Girard, MD; Louise Lim, MD
- Nicolas Girard, MD
- Louise Lim, MD
- Jacob Sands, MD
- Stephanie McDonald, MSN, FNP-BC, AOCNP
Addressing Oncology-Related Infertility Through Collaborative Care
Addressing Oncology-Related Infertility Through Collaborative Care
Clinician's Roundtable
Addressing Oncology-Related Infertility Through Collaborative Care
Irene Su, MD, MSCE
- Irene Su, MD, MSCE
6-Year CheckMate 9LA Data in PD-L1-Negative NSCLC: Implications for Care
6-Year CheckMate 9LA Data in PD-L1-Negative NSCLC: Implications for Care
Project Oncology®
6-Year CheckMate 9LA Data in PD-L1-Negative NSCLC: Implications for Care
Steve Jackson, PharmD; Lyudmila A. Bazhenova, MD
- Steve Jackson, PharmD
- Lyudmila A. Bazhenova, MD
Ongoing Trials in Oral Targeted Strategies in Breast Cancer
Ongoing Trials in Oral Targeted Strategies in Breast Cancer
MinuteCE®
Ongoing Trials in Oral Targeted Strategies in Breast Cancer
Aditya Bardia, MD, MPH, FASCO
0.50 program credits
- Aditya Bardia, MD, MPH, FASCO
0.50 program credits